SCMP Share Price |
||||
| Open | 10.65 | Change | Price | % |
| High | 10.65 | 1 Day | -0.15 | -1.41 |
| Low | 10.35 | 1 Week | 0.15 | 1.45 |
| Close | 10.50 | 1 Month | 0.85 | 8.81 |
| Volume | 438577 | 1 Year | -1.36 | -11.47 |
| 52 Week High 17.55 | ||||
| 52 Week Low 9.30 | ||||
| SCMP Important Levels | |
| Resistance 2 | 10.78 |
| Resistance 1 | 10.66 |
| Pivot | 10.50 |
| Support 1 | 10.34 |
| Support 2 | 10.22 |
| NASDAQ USA Most Active Stocks | |||
| FNFG | 10.18 | -0.20% | |
| ASTI | 0.00 | 0.00% | |
| DELL | 13.86 | 0.22% | |
| RFMD | 16.59 | -2.07% | |
| RIMM | 13.03 | 0.39% | |
| BBEP | 0.12 | 0.00% | |
| GTAT | 0.44 | 0.00% | |
| SUSQ | 14.20 | -0.77% | |
| ACAS | 17.99 | 0.39% | |
| DCTH | 0.02 | -33.33% | |
| NASDAQ USA Top Gainers Stocks | |||
| HMNY | 3.81 | 55.51% | |
| LOCM | 0.09 | 50.00% | |
| GSOL | 17.88 | 49.00% | |
| OPXAW | 0.04 | 33.33% | |
| WRES | 0.09 | 28.57% | |
| CGEI | 0.28 | 27.27% | |
| BSDM | 0.62 | 26.53% | |
| SNTA | 0.34 | 25.93% | |
| OTT | 2.39 | 25.13% | |
| BEBE | 4.67 | 23.22% | |
| NASDAQ USA Top Losers Stocks | |||
| TXCC | 0.01 | -95.00% | |
| HCIIP | 10.10 | -67.52% | |
| HAUP | 0.07 | -58.82% | |
| CRMB | 0.27 | -57.81% | |
| KIOR | 0.03 | -57.14% | |
| SPIR | 0.01 | -50.00% | |
| OSH | 0.26 | -49.02% | |
| OSH | 0.26 | -49.02% | |
| DVOX | 0.05 | -44.44% | |
| PRXI | 0.21 | -43.24% | |
Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP)
| SCMP Technical Analysis | 2 |
| As on 23rd May 2017 SCMP Share Price closed @ 10.50 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 12.04 & Buy for SHORT-TERM with Stoploss of 10.44 we also expect STOCK to react on Following IMPORTANT LEVELS. | |
| SCMP Target for May | |
| 1st Target up-side | 11.08 |
| 2nd Target up-side | 11.73 |
| 3rd Target up-side | 12.38 |
| 1st Target down-side | 9.22 |
| 2nd Target down-side | 8.57 |
| 3rd Target down-side | 7.92 |
Sucampo Pharmaceuticals, Inc. ( NASDAQ USA Symbol : SCMP ) Sector : Healthcare And Other Stocks in Same Sector |
|||||
|
ABAX
48.12 0.28 (0.59 %) LT : Sell ST : Buy |
ABIO
2.35 -0.05 (-2.08 %) LT : Sell ST : Strong Sell |
ABMD
134.74 -1.06 (-0.78 %) LT : Strong Buy ST : Strong Buy |
ACAD
27.55 -0.46 (-1.64 %) LT : Sell ST : Strong Sell |
ACHC
43.16 -0.54 (-1.24 %) LT : Sell ST : Sell |
|
|
|
||||||||||||||||||||||
|
Interactive Technical Analysis Chart Sucampo Pharmaceuticals, Inc. ( SCMP NASDAQ USA )
Your Comments and Response on Sucampo Pharmaceuticals, Inc.
SCMP Business Profile
Sucampo Pharmaceuticals, Inc. is a global biopharmaceutical company focused on research, discovery, development and commercialization of drugs based on ion channel activators known as prostones. The Company�s prostone-based compounds target the ClC-2 and big potassium (BK), ion channels. It is focused on developing prostones to treat gastrointestinal, ophthalmic, neurologic, and oncology-based inflammatory disorders, and is also considering other therapeutic applications of its drug technology. The Company�s products include AMITIZA (lubiprostone) and RESCULA (unoprostone isopropyl). AMITIZA is marketed in the United States for three gastrointestinal indications: chronic idiopathic constipation (CIC), in adults, irritable bowel syndrome with constipation (IBS-C), in adult women, and opioid-induced constipation (OIC), in adult patients with chronic, non-cancer pain. RESCULA is a BK channel activator and has a different mechanism of action than other IOP lowering agents on the market.